Literature DB >> 8227310

Beta-endorphin protects mice from neurological disease induced by the murine coronavirus MHV-JHM.

W Gilmore1, D S Moradzadeh.   

Abstract

The neurotropic murine coronavirus, MHV-JHM (JHMV) causes encephalitis and paralytic-demyelinating disease in susceptible strains of mice and rats, serving as a model for human demyelinating diseases such as multiple sclerosis. In this communication, we report that a single intracerebral administration of the naturally occurring neuropeptide, beta-endorphin, reduced the incidence of JHMV-induced paralytic-demyelinating disease 40-50% in C57Bl/6 mice. Protection from disease was accompanied by significantly reduced virus replication in the brain as early as 3 days post-infection and did not occur in irradiated, or immunoincompetent mice. The data suggest that beta-endorphin engages immune mechanisms of host resistance to JHMV infection to protect the mice from disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227310      PMCID: PMC7119610          DOI: 10.1016/0165-5728(93)90061-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  54 in total

1.  Immunopathogenesis of demyelination induced by MHV-4.

Authors:  J O Fleming; F I Wang; M D Trousdale; D R Hinton; S A Stohlman
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

Review 2.  Opioid peptides and opioid receptors in cells of the immune system.

Authors:  N E Sibinga; A Goldstein
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

3.  Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies.

Authors:  P W Lampert; J K Sims; A J Kniazeff
Journal:  Acta Neuropathol       Date:  1973-03-30       Impact factor: 17.088

4.  Chronic central nervous system demyelination in mice after JHM virus infection.

Authors:  S A Stohlman; L P Weiner
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

5.  Modulation of human neutrophil adherence by beta-endorphin and met-enkephalin.

Authors:  D E Van Epps; S L Kutvirt
Journal:  J Neuroimmunol       Date:  1987 Jul-Aug       Impact factor: 3.478

6.  Coronavirus-induced CNS disease: a model for virus-induced demyelination.

Authors:  M J Buchmeier; R G Dalziel; M J Koolen
Journal:  J Neuroimmunol       Date:  1988-12       Impact factor: 3.478

7.  Coronavirus induced primary demyelination: indications for the involvement of a humoral immune response.

Authors:  F Zimprich; J Winter; H Wege; H Lassmann
Journal:  Neuropathol Appl Neurobiol       Date:  1991-12       Impact factor: 8.090

8.  Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM.

Authors:  N La Monica; L R Banner; V L Morris; M M Lai
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

9.  Beta-endorphin alters a viral induced central nervous system disease in normal mice but not in nude mice.

Authors:  S C Doll; T C Johnson
Journal:  J Neuroimmunol       Date:  1989-09       Impact factor: 3.478

10.  Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM.

Authors:  J S Williamson; K C Sykes; S A Stohlman
Journal:  J Neuroimmunol       Date:  1991-06       Impact factor: 3.478

View more
  2 in total

Review 1.  Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis.

Authors:  Vishakha Singh; Prince Allawadhi; Amit Khurana; Anil Kumar Banothu; Kala Kumar Bharani
Journal:  Sens Int       Date:  2021-05-13

Review 2.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.